tradmap

AEHR Aehr Test Systems

$59.26 +8.04%

Data as of close

Healthcare · Instruments For Meas & Testing Of Electricity & Elec Signals

Aehr Test Systems (AEHR) is a healthcare company in the Instruments For Meas & Testing Of Electricity & Elec Signals industry, with a market capitalization of $1.9 billion. Shares last traded at $59.26, 59.8% below their 52-week high. Over the past year the stock is up 135.7%. Net profit margin is -14.3%, below the peer median of 2.6%. Revenue declined 15.2% year over year.

Market Cap
$1.9B
Shares Out
32.6M
EPS (TTM)
-$0.23
P/E (TTM)*
—
P/S Ratio
38.66
P/B Ratio
8.81
Dividend / Share
—
Dividend Yield
—
52-Week High
$147.40
52-Week Low
$18.71
Volume (venue)
179,002
Avg Vol (3m, venue)
87,210.238

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+4.51%
1M
-44.80%
3M
-45.14%
6M
-30.80%
YTD
+193.95%
1Y
+135.72%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
37.99
SMA (50)
$82.95
SMA (200)
$74.69
Price vs SMA50
-28.56%
Price vs SMA200
-20.66%
ATR (14)
$7.46

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$50M
Net Income
-$7M
Gross Margin
35.3%
Operating Margin
-28.3%
Net Margin
-14.3%
Return on Equity
-3.2%
Return on Assets
-2.9%
Current Ratio
10.33
Debt / Equity
0.00
Revenue Growth (YoY)
-15.2%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-05-29. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q4 2026 (derived) $0.05 2026-07-27
FY 2026 -$0.23 2026-07-27
Q3 2026 -$0.10 2026-04-08
Q2 2026 -$0.11 2026-01-12
Q1 2026 -$0.07 2025-10-08
FY 2025 -$0.13 2025-07-28

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Instruments For Meas & Testing Of Electricity & Elec Signals peers

AEHR vs 10 industry peers (Instruments For Meas & Testing Of Electricity & Elec Signals), by market cap. Data as of close

P/S vs peers
38.66 / 3.26 med
+1088% premium
Net margin vs peers
-14.3% / 2.6% med
below median
1–10 of 10
TERTeradyne$40.7B29.668.1427.5%-4.82%
VLTOVeralto$28.1B28.084.8517.3%+4.18%
ITRIItron, Inc.$4.4B15.641.8912.1%+4.01%
COHUCohu Inc$2.3B—4.02-4.0%-4.89%
AEHRAehr Test Systems$1.9B—38.66-14.3%+8.04%
ALNTAllient Inc$1.4B50.032.495.0%-1.55%
TRNSTranscat Inc$822M152.832.361.5%+1.73%
FEIMFREQUENCY ELECTRONICS INC$740M276.3010.163.7%-3.26%
INTTINTEST CORP$175M295.731.440.5%-2.90%
DAIODATA I/O CORP$24M—1.37-50.1%-1.67%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.